Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on chiral resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116396189A details a novel B(C6F5)3 catalyzed route for high-purity (S)-(+)-1-indanyl isocyanate, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Advanced patent-based method for solifenacin intermediate production offering high purity and reduced waste for global pharmaceutical supply chains.
Novel patent CN121342695A offers scalable chiral amino acid synthesis. Reduces waste and cost for IL-17 inhibitor intermediates. Reliable supply chain partner.
Patent CN109503462B details a novel synthesis for Tofacitinib intermediates, offering improved stereoselectivity and cost reduction in API manufacturing through optimized catalytic hydrogenation.
Patent CN109734653B details a superior chiral resolution method for Argatroban precursors using L-dibenzoyltartaric acid, offering enhanced purity and cost-effective manufacturing scalability.
Patent CN119306645A reveals advanced pyrrolamide synthesis. Enables cost reduction in pharmaceutical intermediates manufacturing with scalable, high-yield processes.
Patent CN116396189B details a novel boron-catalyzed route for high-purity chiral intermediates, offering significant supply chain stability and cost optimization for global pharmaceutical manufacturers.
Patent CN113896645A reveals a one-pot synthesis method for D-p-HPG. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN1915974A details NMP-based chiral resolution for high-purity Amlodipine. Offers significant cost reduction and supply chain reliability for API manufacturing partners.
Patent CN107151246B reveals cost-effective chiral resolution. Reliable supplier for high-purity levo-praziquantel intermediates with scalable processes.
Novel resolution process enhances purity and supply continuity for D-Calcium Pantothenate manufacturing reducing costs significantly for global buyers.
Patent CN112479876B details a novel chiral resolution method for oxazepane spiro compounds, offering improved stereoselectivity and streamlined manufacturing for global supply chains.
Novel synthesis route for chiral nitrophenol intermediates reduces cost and improves purity. Reliable supply for pharmaceutical manufacturing scale-up.
Advanced preparation method for (R)-1-Boc-3-aminopiperidine via chiral resolution. Safe, scalable process for DPP-IV inhibitor intermediates with reduced costs.
Discover the novel one-step preparation and resolution of 2-acylamino-3-biphenylpropionic acid. A cost-effective, high-purity route for API manufacturing.
Patent CN101935309A reveals a novel Ezetimibe synthesis using indeno-oxazole auxiliaries, offering 99.97% ee and scalable manufacturing for reliable API intermediate supply chains.
Patent CN108864252B reveals a scalable liquid-phase synthesis for NRX-1074, offering high purity without preparative HPLC for reliable API intermediate supply.
Novel resolution method using ethyl acetate and ethanol mixtures ensures high optical purity and yield for scalable antidepressant intermediate production.
Novel quinine-based resolution method for (S)-oxiracetam ensures high optical purity and scalable production for pharmaceutical supply chains.
Novel chiral resolution method using aspartic acid eliminates chromatography, offering high purity and scalable production for pharmaceutical intermediates.